Table 2 Association of reduced RBM4 expression with clinicopathological characteristics in gastric cancer patients.
From: Prognostic value of decreased expression of RBM4 in human gastric cancer
Characteristics: | n | RBM4+ | PearsonX2 | P-value |
|---|---|---|---|---|
Total | 605 | 265(43.8%) | ||
Gender | 1.490 | 0.222 | ||
Male | 458 | 207(45.2%) | ||
Female | 147 | 58(39.5%) | ||
Age | 0.635 | 0.425 | ||
<60 | 367 | 156(42.5%) | ||
≥60 | 238 | 109(45.8%) | ||
Histological type | 7.382 | 0.117 | ||
Tubular | 528 | 237(44.9%) | ||
Mucinous | 9 | 4(44.4%) | ||
Mixeda | 34 | 14(41.2%) | ||
Signet ring cell | 23 | 4(17.4%) | ||
Othersb | 11 | 6(54.5%) | ||
Differentiation | 31.477 | <0.001* | ||
Well | 37 | 25(67.6%) | ||
Moderate | 224 | 122(54.5%) | ||
Poor | 278 | 96(34.5%) | ||
Othersc | 66 | 22(33.3%) | ||
TNM stage | 6.060 | 0.014* | ||
0+I+II | 352 | 169(48.0%) | ||
III+IV | 253 | 96(37.9%) | ||
Depth of invasion | 2.695 | 0.101 | ||
Tis+ T1+T2 | 220 | 106(48.2%) | ||
T3+T4 | 385 | 159(41.3%) | ||
Lymph node metastasis | 9.272 | 0.026* | ||
N0 | 246 | 123(50.0%) | ||
N1 | 107 | 47(43.9%) | ||
N2 | 122 | 51(41.8%) | ||
N3 | 130 | 44(33.8%) | ||
Distant metastasis | 4.392 | 0.036* | ||
M0 | 560 | 252(45.0%) | ||
M1 | 45 | 13(28.9%) |
